Talk:4-FMC: Difference between revisions
>David Hedlund Vault |
>MeyveliPasta Turkey legality |
||
(33 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{ | {{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}} | ||
{{ | {{headerpanel| {{approval}}}} | ||
{ | {{SummarySheet}} | ||
{{Template talk:SubstanceBox/4-FMC}} | |||
'''Flephedrone''', also known as '''4-fluoromethcathinone''' ('''4-FMC'''), is a synthetic [[psychoactive class::stimulant]] drug of the [[amphetamine]] and [[Substituted cathinone|cathinone]] classes. | '''Flephedrone''', also known as '''4-fluoromethcathinone''' ('''4-FMC'''), is a synthetic [[psychoactive class::stimulant]] drug of the [[amphetamine]] and [[Substituted cathinone|cathinone]] classes. | ||
Line 14: | Line 12: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | |||
Given its chemical structure, flephedrone is likely to act as a [[releasing agent]] and a [[reuptake inhibitor]] for monoamine [[neurotransmitters]] such as [[dopamine]], [[serotonin]] and [[noradrenaline]]. | Given its chemical structure, flephedrone is likely to act as a [[releasing agent]] and a [[reuptake inhibitor]] for monoamine [[neurotransmitters]] such as [[dopamine]], [[serotonin]] and [[noradrenaline]]. | ||
Flephedrone is likely to have a similar pharmacological profile to mephedrone. | Flephedrone is likely to have a similar pharmacological profile to mephedrone. | ||
Line 19: | Line 18: | ||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | |||
|{{effects/physical| | |||
*'''[[Effect::Spontaneous tactile sensations]]''' - The "body high" of flephedrone can be described as a moderate to extreme euphoric tingling sensation that encompasses the entire body. It is capable of becoming overwhelmingly pleasurable at higher dosages. This sensation maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached. | *'''[[Effect::Spontaneous tactile sensations]]''' - The "body high" of flephedrone can be described as a moderate to extreme euphoric tingling sensation that encompasses the entire body. It is capable of becoming overwhelmingly pleasurable at higher dosages. This sensation maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached. | ||
*'''[[Effect::Stimulation]]''' - In terms of its effects on the user's physical energy levels, flephedrone is commonly considered to be extremely stimulating and energetic. This encourages activities such as running, climbing and dancing. The particular style of stimulation which flephedrone presents can be described as forced. This means that at higher dosages it becomes difficult or impossible to keep still, as jaw clenching, involuntarily bodily shakes and vibrations become present, resulting in an extreme unsteadiness of the hands and a general lack of motor control. | *'''[[Effect::Stimulation]]''' - In terms of its effects on the user's physical energy levels, flephedrone is commonly considered to be extremely stimulating and energetic. This encourages activities such as running, climbing and dancing. The particular style of stimulation which flephedrone presents can be described as forced. This means that at higher dosages it becomes difficult or impossible to keep still, as jaw clenching, involuntarily bodily shakes and vibrations become present, resulting in an extreme unsteadiness of the hands and a general lack of motor control. | ||
Line 31: | Line 31: | ||
*'''[[Effect::Increased blood pressure]]''' | *'''[[Effect::Increased blood pressure]]''' | ||
*'''[[Effect::Body odor alteration]]''' | *'''[[Effect::Body odor alteration]]''' | ||
*'''[[Effect::Teeth grinding]]''' - This component can be considered to be less intense when compared with that of [[MDMA]]. | *'''[[Effect::Teeth grinding]]''' - This component can be considered to be less intense when compared with that of [[MDMA]].}} | ||
|{{effects/cognitive| | |||
The cognitive effects of flephedrone can be broken down into several components which progressively intensify proportional to dosage. The general head space of mephedrone is described by many as one of extreme mental stimulation and powerful euphoria. It contains a large number of typical [[Stimulants|stimulant]] cognitive effects. | The cognitive effects of flephedrone can be broken down into several components which progressively intensify proportional to dosage. The general head space of mephedrone is described by many as one of extreme mental stimulation and powerful euphoria. It contains a large number of typical [[Stimulants|stimulant]] cognitive effects. | ||
Line 50: | Line 49: | ||
*'''[[Effect::Increased libido]]''' | *'''[[Effect::Increased libido]]''' | ||
*'''[[Effect::Increased music appreciation]]''' | *'''[[Effect::Increased music appreciation]]''' | ||
}} | |||
{{effects/aftereffects| | |||
The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. Its effects commonly include: | The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. Its effects commonly include: | ||
*'''[[Effect::Anxiety]]''' | *'''[[Effect::Anxiety]]''' | ||
Line 60: | Line 59: | ||
*'''[[Effect::Thought deceleration]]''' | *'''[[Effect::Thought deceleration]]''' | ||
*'''[[Effect::Wakefulness]]''' | *'''[[Effect::Wakefulness]]''' | ||
}}}} | |||
===Experience reports=== | ===Experience reports=== | ||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | ||
Line 65: | Line 65: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{toxicity}} | |||
{{Further|Research chemicals#Toxicity and harm potential}} | {{Further|Research chemicals#Toxicity and harm potential}} | ||
Almost nothing is known about the long-term effects of flephedrone due to its short history of its use. The [[Toxicity::exact toxic dosage is unknown]]. | Almost nothing is known about the long-term effects of flephedrone due to its short history of its use. The [[Toxicity::exact toxic dosage is unknown]]. | ||
Line 75: | Line 76: | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
{{DangerousInteractions}} | |||
{{DangerousInteractions/Intro}} | {{DangerousInteractions/Intro}} | ||
{{DangerousInteractions/Stimulants|self=[[Substituted cathinone|cathinone]]s}} | {{DangerousInteractions/Stimulants|self=[[Substituted cathinone|cathinone]]s}} | ||
====[[Serotonin syndrome]] risk==== | ====[[Serotonin syndrome]] risk==== | ||
Line 84: | Line 84: | ||
==Legal issues== | ==Legal issues== | ||
{{LegalStub}} | |||
*'''Turkey:''' 4-FMC is a classed as drug and is illegal to possess, produce, supply, or import.<ref>Bakanlar Kurulu Kararı Karar Sayısı : 2013/4827 | https://free-ankara.org/wp-content/uploads/2017/09/BKK_2013_4827_28688.pdf</ref> | |||
*'''United Kingdom:''' It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. <ref>http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | *'''United Kingdom:''' It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. <ref>http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | ||
Line 96: | Line 98: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Flephedrone Flephedrone (Wikipedia)] | *[https://en.wikipedia.org/wiki/Flephedrone Flephedrone (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/ | *[https://www.erowid.org/chemicals/4_fluoromethcathinone/ Flephedrone (Erowid Vault)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=2112 4-FMC (Isomer Design)] | |||
==References== | ==References== | ||
Line 103: | Line 106: | ||
[[Category:Cathinone]] | [[Category:Cathinone]] | ||
[[Category:Stimulant]] | [[Category:Stimulant]] | ||
[[Category:Articles in talk page]] | |||
{{#set:Featured=true}} | {{#set:Featured=true}} |